9886 Stock Overview
Dingdang Health Technology Group Ltd. operates as a service provider in the digital retail pharmacy industry in the People’s Republic of China.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Dingdang Health Technology Group Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$1.12 |
52 Week High | HK$4.09 |
52 Week Low | HK$1.14 |
Beta | 0 |
1 Month Change | -26.80% |
3 Month Change | -44.00% |
1 Year Change | -70.45% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -90.67% |
Recent News & Updates
Recent updates
Shareholder Returns
9886 | HK Consumer Retailing | HK Market | |
---|---|---|---|
7D | -5.9% | -6.5% | 0.3% |
1Y | -70.4% | -55.2% | -12.7% |
Return vs Industry: 9886 underperformed the Hong Kong Consumer Retailing industry which returned -55.2% over the past year.
Return vs Market: 9886 underperformed the Hong Kong Market which returned -12.7% over the past year.
Price Volatility
9886 volatility | |
---|---|
9886 Average Weekly Movement | 5.0% |
Consumer Retailing Industry Average Movement | 8.3% |
Market Average Movement | 7.3% |
10% most volatile stocks in HK Market | 14.7% |
10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 9886's share price has been volatile over the past 3 months.
Volatility Over Time: 9886's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | 2,605 | Wenlong Yang | https://www.ddjkjt.com |
Dingdang Health Technology Group Ltd. operates as a service provider in the digital retail pharmacy industry in the People’s Republic of China. The company offers pharmaceutical retail and medical consultation services.
Dingdang Health Technology Group Ltd. Fundamentals Summary
9886 fundamental statistics | |
---|---|
Market cap | HK$1.56b |
Earnings (TTM) | -HK$2.56b |
Revenue (TTM) | HK$4.96b |
0.3x
P/S Ratio-0.6x
P/E RatioIs 9886 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9886 income statement (TTM) | |
---|---|
Revenue | CN¥4.59b |
Cost of Revenue | CN¥3.12b |
Gross Profit | CN¥1.47b |
Other Expenses | CN¥3.84b |
Earnings | -CN¥2.37b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Mar 28, 2024
Earnings per share (EPS) | -1.77 |
Gross Margin | 32.00% |
Net Profit Margin | -51.63% |
Debt/Equity Ratio | 0% |
How did 9886 perform over the long term?
See historical performance and comparison